← All Investors
LB PHARMACEUTICALS INC
LBRX
Holders
2
Combined Value
$13M
Combined Shares
553,872
Current Price
$30.05
52W High
$33.47
vs 52W High
−10.2%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Ken Griffin - Citadel Advisors | $10M | 0.00% | ~$15.99 | +88.0% | Bought Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $3.4M | 0.00% | ~$24.66 | +21.9% | Bought Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Israel Englander - Millennium Management | NEW BUY | +$3.4M | ~$24.66 |
| Q1 2026 | Ken Griffin - Citadel Advisors | BUY | +$227K | ~$24.66 |
| Q4 2025 | Israel Englander - Millennium Management | SOLD OUT | −$8.5M | ~$15.79 |
| Q4 2025 | Ken Griffin - Citadel Advisors | SELL | −$2.9M | ~$22.26 |
| Q3 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$8.5M | ~$15.79 |
| Q3 2025 | Israel Englander - Millennium Management | NEW BUY | +$8.5M | ~$15.79 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 553,872 | +35.9% | $13M | $24.66 |
| Q4 2025 | 1 | 407,668 | −62.2% | $9.1M | $22.26 |
| Q3 2025 | 2 | 1,077,539 | — | $17M | $15.79 |